Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Aspen Pharmacare Holdings Ltd banner
A

Aspen Pharmacare Holdings Ltd
SWB:LDZA

Watchlist Manager
Aspen Pharmacare Holdings Ltd
SWB:LDZA
Watchlist
Price: 7.65 EUR -6.71% Market Closed
Market Cap: €3.4B
Write Note Create Alert Ask AI

Wall St Price Targets

LDZA Price Targets Summary
Aspen Pharmacare Holdings Ltd

Wall Street analysts forecast LDZA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LDZA is 8.9 EUR with a low forecast of 8.12 EUR and a high forecast of 9.44 EUR.

LDZA Lowest Forecast
Wall Street Target
€8.12
6% Upside
LDZA Average Forecast
Wall Street Target
€8.9
16% Upside
LDZA Highest Forecast
Wall Street Target
€9.44
23% Upside
Lowest Forecast
Price Target
8.12 EUR
6% Upside
Average Forecast
Price Target
8.9 EUR
16% Upside
Highest Forecast
Price Target
9.44 EUR
23% Upside
Aspen Pharmacare Holdings Ltd Competitors:
Price Targets

Revenue
Forecast

6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 2 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 2 years is 12%.

What are analyst estimates?

Operating Income
Forecast

-2% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-2% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 2 years is 51%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

What are analyst estimates?

Net Income
Forecast

0% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
0% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 22%.

What are analyst estimates?

Continue LDZA Research

Summary
LDZA intrinsic value, competitors valuation, and company profile.
DCF Valuation
LDZA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LDZA stock valuation using valuation multiples.
Wall St Estimates
LDZA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LDZA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Aspen Pharmacare Holdings Ltd listings:
OTC • USD
APNHY
 OTC • USD
APNHF
 F • EUR
LDZA
 JSE • Zac
APN
 F • EUR
LDZU
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LDZA's stock price target?
Price Target
8.9 EUR

According to Wall Street analysts, the average 1-year price target for LDZA is 8.9 EUR with a low forecast of 8.12 EUR and a high forecast of 9.44 EUR.

What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 2 years is 11%.

What is the Gross Profit forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 2 years is 12%.

What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
51%

Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 2 years is 51%.

What is the Net Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.